Iatrogenic alogenosis and rheumatic diseases
DOI:
https://doi.org/10.5281/zenodo.1211650Keywords:
Iatrogenic allogenosis, biopolymers, filling substances, plastic surgery, autoimmune/inflammatory syndrome induced by adjuvantsAbstract
The application of substances with aesthetic purpose in an indiscriminate way as oils minerals, hydrocarbons, industrial silicon, and others, they take to produce illnesses well in the body it is local and/or systemic. The association between the use of these substances and the appearance of autoimmunity diseases is not still clear. Nevertheless cases series have been described patient with antecedent of injection for filler materials with cosmetics purpose that later presented defined autoimmunity such as systemic sclerosis, lupus, rheumatoid arthritis, Sjögren Syndrome, Fibromyalgia and the isolated presence of some symptoms nonspecific. The excessive inflammatory reaction that can cause these substances and their serious consequences for the organism, and keeping in mind the increase from these practices to global level is necessary to inform that alone through an appropriate education to the community and the preparation of the health professionals will be able to prevent and combat the terrible damage in the population.
Downloads
References
Cardona González MA. Dermatología y Cirugía Plástica: Alogenosis Iatrogénica: Biopolímeros y otras sustancias [Internet]. Dermatología y Cirugía Plástica. [citado 2 de febrero de 2018]. Disponible en: http://dermatologiaycirugiaplastica.blogspot.com/p/alogenosis-iatrogenica-biopolimeros-y.html
Gómez BT, Vargas RB, Ramírez GM, Blancas RBP. Instrumento para evaluar y estadificar el daño producido por la infiltración de sustancias modelantes. Cir Plast. 2010;20(3):105-11.
Behar T, Anderson EE, Barwick WJ. Sclerosing Lipogranulomatosis: A case report of scrotal injection of automobile transmission fluid and literature review of subcutaneous injection of oils. Plast Reconstr Surg. 1993;91(2):352-61.
Vera-Lastra O, Medina G, Cruz-Dominguez MDP, Jara LJ, Shoenfeld Y. Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld’s syndrome): clinical and immunological spectrum. Expert Review of Clinical Immunology. 2013;9(4):361-73.
Gordillo-Hernández J, Alegre-Tamez E, Torres-Baltazar I, Mendieta-Espinosa MJ, Sastré-Ortiz N. Abordaje multidisciplinario de la enfermedad humana por infiltración de sustancias modelantes. Cirugía Plástica Ibero-Latinoamericana. 2013;39(3):269-77.
Ramírez DAC, Cobo DADP, Peñaloza JAC, Rivera DAE, Villota AIR. Alogenosis Iatrogénica vs Alogenosis Secundaria en Cali. A propósito de 12 casos. Colombia Forense. 2016;3(2):63-74.
Castro LFG, Rueda JDA, Calle HDJC. Análisis infrarrojo del hialucorp, metacorp y silicona líquida en el marco de la alogenosis iatrogénica. Revista Colombiana de Cirugía Plástica y Reconstructiva [Internet]. 2017 [citado 2 de febrero de 2018];23(1). Disponible en: http://www.ciplastica.com/ojs/index.php/rccp/article/view/37
Neligan PC. Soft-tissue fillers. En: Plastic Surgery. Tercera Edición. Amsterdam: Elsevier; 2013. p. 44-59.
Sanz-Barriga HA, Revilla E, Pedro C. Alogenosis Iatrogénica, el Gran Peligro de los Biopolímeros. Rev Cient Cienc Med. 2010;13(1):31-4.
Coiffman F. Alogenosis iatrogénica: Una nueva enfermedad. Cirugía Plástica Ibero-Latinoamericana. 2008;34(1):1-10.
Coleman SR. Avoidance of Arterial Occlusion From Injection of Soft Tissue Fillers. Aesthet Surg J. 2002;22(6):555-7.
Zsigmond R, Ungureanu C, Blagosklonov O, Biancheri I, Angoue O, Runge M, et al. Bone Scintigraphy Pattern of Joint Chronic Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation. Clin Nucl Med. 2009;34(1):20-3.
Necas A, Planka L, Srnec R, Crha M, Hlucilova J, Klima J, et al. Quality of Newly Formed Cartilaginous Tissue in Defects of Articular Surface after Transplantation of Mesenchymal Stem Cells in a Composite Scaffold Based on Collagen I with Chitosan Micro- and Nanofibres. Physiol Res. 2010;59(4):605-14.
Shoenfeld Y, Agmon-Levin N. ASIA- Autoimmune/inflammatory syndrome induced by adjuvant. J Autoimmun. 2011;36:4-8.
Jarrot PA, Leone J, Brochot P, Pennaforte JL. Achilles tendinitis in systemic lupus erythematosus: search for an associated inflammatory disease. Lupus. 2015;24(12):1318-20.
Vera-Lastra O, Medina G, Cruz-Dominguez MP, Ramírez P, Gayosso-Rivera JA, Anduega-Dominguez H, et al. Human adjuvant disease induced by foreign substances: a new model of ASIA (Shoenfeld`s syndrome). Lupus. 2012;21:128-35.
Zulfiqar A-A, Courtel T, Novella J-L, Pennaforte J-L. [Late-onset lupus in the elderly after 65 years: retrospective study of 18 cases]. Geriatr Psychol Neuropsychiatr Vieil. 2015;13(2):157-68.
Caldeira AML, Robles-Mejía MB. Reconstrucción estética de labio superior tras necrosis secundaria a infiltración de material aloplástico. Cirugía Plástica Ibero-Latinoamericana. 2015;41(1):83-90.
Torres Gómez B, Medrano Ramírez G, Priego Blancas RB, Pelaez Ballestas I, Burgos Vargas R. Enfermedad por la infiltración de sustancias modelantes con fines estéticos. Cirugía Plástica. 2010;20:124-32.
Martínez‐Villarreal Ashley A, Asz‐Sigall Daniel, Gutiérrez‐Mendoza Daniela, Serena Thomas E, Lozano‐Platonoff Adriana, Sanchez‐Cruz Lourdes Y, et al. A case series and a review of the literature on foreign modelling agent reaction: an emerging problem. International Wound Journal. 2016;14(3):546-54.
Párraga de Zoghbi B, Pérez Alfonzo R, Gutierrez-González LA. Alogenosis iatrogénica: aproximación terapéutica. PANLAR 2012. En Punta Cana; 2012.
Alogenosis Iatrogénica ¿una nueva enfermedad? [Internet]. Granma.cu. [citado 2 de febrero de 2018]. Disponible en: http://www.granma.cu/todo-salud/2016-05-29/alogenosis-iatrogenica-una-nueva-enfermedad-29-05-2016-22-05-28
Published
How to Cite
Issue
Section
License
Warning of rights of author
The authors that publish in this journal agree with the following terms:
The authors conserve the rights of author and concede to the journal the right of the first publication, fulfilling with the license Creative Commons Attribution License that allows to others share the work with recognition of the authorship of their articles, and the initial publication in this journal.
The authors can establish separately additional agreements for the no exclusive distribution of the version of the work published in the journal (for example, situate it in an institutional repository, in a personal blog or publish it partial or totally in a book), with a recognition of their initial publication in this journal.
To be able to send the manuscript or part of him passed three months of published, for his evaluation to other publishers, identifying it or not with the same title; whenever allusion is made to our journale and know it the new publisher.
The publishing committee of the Cuban Journal of Rheumatology authorizes to other publishers, to reproduce the articles published in our magazine, whenever it indicate the origin of the same.
The authors should send a document in Office Word application format through the electronic address of the magazine with a similar format to that we include next:
---------------------------------------------------------------------------------------------------------------------
Statement of authorship and cede of articles for the publication of the scientific work in the Cuban Journal of Rheumatology
Date:
Those who subscribe certify that are the authors of the work:
Of this form communicate the originality of our article clearing that the concepts and knowledges of other authors that have included in the text of the article, have been quoted properly in the bibliography.
We do proof besides that the article in question is original and has not been published, total neither partially, in another journal.
To be approved for his publication in the Cuban Journal of Rheumatology, do secession of the rights of publication to the same one through the method that realizes it usually.
In front of any catchword that exist by the article that send to evaluate, relieve of of the responsibility to the Cuban Journal of Rheumatology holding us responsible with all the difficulties that can berelated by any situation.
We include to continuation the name and the signature of all authors and collaborators of this article.
Name: Signature:
